News | Brachytherapy Systems | March 18, 2016

Global Brachytherapy Market Reaches $705 Million in 2015

MEDraysintell projects 8 percent annual growth through 2030 to a total value of $2 billion

global brachytherapy market value, MEDraysintell

March 18, 2016 — The global market for brachytherapy reached $705 million in 2015, according to a report from MEDraysintell. Of that total, the high-dose rate (HDR) and low-dose-rate (LDR) segments accounted for just over 60 percent, while the microspheres and electronic brachytherapy commanded the remaining 40 percent.

The global brachytherapy market in 2015, expressed in U.S. dollars, has been affected by exchange rate fluctuations of the major currencies against the U.S. dollar. The brachytherapy market size displayed an annual growth of 3 percent during the last two years to reach $705 million in 2015. Without this exchange rate influence, MEDraysintell estimates that the brachytherapy market would have reached about $800 million, thereby exhibiting an annual growth of more than 8 percent.

The brachytherapy market is expected to reach $2 billion in 2030, growing by 8 percent annually, mainly driven by the microspheres market as well as electronic brachytherapy, which is gaining significant interest worldwide as a user-friendly technology. The LDR brachytherapy seeds market is expected to grow substantially in new large markets such as China and India because of its reduced cost, together with a high therapeutic success rate.

The top ten companies control about 80 percent of the world brachytherapy market and more than 20 companies share the remaining 20 percent. Several new companies have penetrated the brachytherapy market in the last few years and a few others are expected to join the market in the coming years.

For more information: www.medraysintell.com

Related Content

Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America
Videos | Radiation Therapy | August 13, 2018
A discussion with Mahadevappa Mahesh, MS, Ph.D., FAAPM, FACR, FACMP, FSCCT, professor of radiology and cardiology and
Overlay Init